MindWalk signs multi-year agreement with Teva Australia to deploy ReefIQ for antibody discovery

MindWalk Holdings Corp. (NASDAQ: HYFT) announced a multi-year agreement with Teva Pharmaceuticals Australia Pty Ltd to support antibody-discovery workflows. Teva Australia will deploy MindWalk's ReefIQ biological context layer, integrated with LensAI analytical capabilities, to aid discovery decisions based on AI-generated predictions.

Detected & updated continuously · Source: Nebula